- Choppy results of late certainly have been affected by the novel coronavirus pandemic — but the core problem with RAD stock still holds.
- Earnings simply have to grow from current levels, and that in turn requires revenue growth that can offset persistent pressures across the business.
- The story here certainly isn't over; investors don't need to flee even after admittedly disappointing first quarter results.
- Still, at some point patience will run out; Rite Aid needs to offer a more credible path to growth than it has at the moment.
For further details see:
Rite Aid: Still Not Good Enough